about
Inhibition of T lymphocyte activation in mice heterozygous for loss of the IMPDH II geneIMP dehydrogenase: structure, mechanism, and inhibition.Why do mutations in the ubiquitously expressed housekeeping gene IMPDH1 cause retina-specific photoreceptor degeneration?Mutations in the inosine monophosphate dehydrogenase 1 gene (IMPDH1) cause the RP10 form of autosomal dominant retinitis pigmentosa.Targeted disruption of the inosine 5'-monophosphate dehydrogenase type I gene in miceAnti-rods/rings autoantibody generation in hepatitis C patients during interferon-α/ribavirin therapyDifferent characteristics and nucleotide binding properties of inosine monophosphate dehydrogenase (IMPDH) isoformsCrystal structure of human type II inosine monophosphate dehydrogenase: implications for ligand binding and drug designLoukoumasomes Are Distinct Subcellular Structures from Rods and Rings and Are Structurally Associated with MAP2 and the Nuclear Envelope in Retinal CellsInositol monophosphatase is a highly conserved enzyme having localized structural similarity to both glycerol 3-phosphate dehydrogenase and haemoglobin.Inosine monophosphate dehydrogenase variability in renal transplant patients on long-term mycophenolate mofetil therapy.Antiproliferative effects of AVN944, a novel inosine 5-monophosphate dehydrogenase inhibitor, in prostate cancer cellsInvestigating the mechanism of disease in the RP10 form of retinitis pigmentosa.Recipient pretransplant inosine monophosphate dehydrogenase activity in nonmyeloablative hematopoietic cell transplantationMycophenolic acid activation of p53 requires ribosomal proteins L5 and L11Integrative analysis of circadian transcriptome and metabolic network reveals the role of de novo purine synthesis in circadian control of cell cycleIMP dehydrogenase from Pneumocystis carinii as a potential drug target.Differential Sensitivities of Fast- and Slow-cycling Cancer Cells to Inosine Monophosphate Dehydrogenase 2 Inhibition by Mycophenolic Acid.Cytoophidium assembly reflects upregulation of IMPDH activity.IMPDH activity in thiopurine-treated patients with inflammatory bowel disease - relation to TPMT activity and metabolite concentrations.Regulation of IMP dehydrogenase gene expression by its end products, guanine nucleotides.Mycophenolate mofetil in the treatment of lupus nephritis.Mycophenolate pharmacokinetics and pharmacodynamics in belatacept treated renal allograft recipients - a pilot studyPharmGKB summary: mycophenolic acid pathway.Lack of cross-resistance to FF-10501, an inhibitor of inosine-5'-monophosphate dehydrogenase, in azacitidine-resistant cell lines selected from SKM-1 and MOLM-13 leukemia cell linesAdenylosuccinate Is an Insulin Secretagogue Derived from Glucose-Induced Purine Metabolism.Novel synthetic route to the C-nucleoside, 2-deoxy benzamide riboside.Base-functionalized carbocyclic nucleosides: design, synthesis, and mechanism of antiviral activity.c-Myc targeted regulators of cell metabolism in a transgenic mouse model of papillary lung adenocarcinomaOverexpression of a cloned IMP dehydrogenase gene of Candida albicans confers resistance to the specific inhibitor mycophenolic acid.Highly selective inhibition of IMPDH2 provides the basis of antineuroinflammation therapy.Hypoxanthine is a checkpoint stress metabolite in colonic epithelial energy modulation and barrier function.IMP/GTP balance modulates cytoophidium assembly and IMPDH activity.
P2860
Q24607219-2B80AF91-6A43-47AC-AFC5-5EB791BCC0AEQ24642299-7EDB7B86-94BF-4D16-B4B8-9FE0537A43F4Q24642828-06D98068-6EB6-4BD6-9D6D-50D6F23BB617Q24655474-E9DD0C54-D0AB-4636-9DE9-93A888541BCCQ24682900-913BA10B-A034-4357-96A9-002356CCBED0Q26766115-CD0D9567-606E-4A51-8164-D68EC650FEDBQ27332315-DC5585CD-906C-44E2-8392-293347DD1D39Q27617777-74EAF000-672D-405D-8E3E-D6F0C901D880Q28553081-F16447D2-E964-476A-B2A7-14CD4862B5DBQ30984239-3E95263B-6925-4F9E-AE9E-280D16ECF8F5Q33696568-8D9D91F8-3F65-4D07-85E1-A7EA51FB4286Q33921228-DE59B642-8757-46E6-93C6-72116D4CEEF7Q33961074-F1B4F71A-21F5-4360-BA7A-7BD10CF827EFQ34175259-6A69E8FE-88B8-4DEF-8BCC-CA411F96846FQ34588852-7C54B2CF-BFCD-496A-B4B8-AF6C8880A2E2Q35122964-6C426DBD-8DE4-4E73-870E-A9D946642693Q35130859-85B89B10-4789-49B6-BA33-CE81EBF75A45Q35807620-3A8C7002-5E12-4D74-8C67-EDA42EE063A4Q36175291-2DDD09E7-D3AE-4F9B-A853-CBBBC93626EBQ36535994-3671C09C-9171-439D-B1F0-C44D07255B31Q36741046-E95E2E26-18F0-4AEC-AAE8-9FD9424030CDQ37290624-396FBF00-2C30-4214-B3D4-2E11FB0A2643Q37299171-4EA182E2-9583-4A4F-A9A8-37BB38F24F17Q38162034-36F04DB6-1626-4391-9880-24AEFEFB52DCQ38762107-7E92ED04-6F82-4A07-AF75-C2AA0067D6CCQ38832035-6FA4B8F7-145A-4823-9EC6-BE1870DBF032Q39314921-CD52CBEB-D793-4817-9697-8E78FFB9434BQ39319202-91126A96-D6B5-4D52-976F-765B0436AD80Q39414698-3B9A5B11-998D-49E6-927A-942AA2BC134BQ39845163-A161CE09-A9CE-4777-A789-C61A2807686AQ41148251-D5DD5C84-B680-4648-9DCB-52604D96A554Q52688916-34B4BAF2-4867-43A8-9C6F-5E3E500D8114Q55382907-6E436B7F-2652-49F7-83BC-9A1A19CBF2D0
P2860
description
1990 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի մարտին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
artículu científicu espublizáu en 1990
@ast
im März 1990 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1990/03/25)
@sk
vědecký článek publikovaný v roce 1990
@cs
wetenschappelijk artikel (gepubliceerd op 1990/03/25)
@nl
наукова стаття, опублікована в березні 1990
@uk
name
Two distinct cDNAs for human IMP dehydrogenase
@ast
Two distinct cDNAs for human IMP dehydrogenase
@en
Two distinct cDNAs for human IMP dehydrogenase
@nl
type
label
Two distinct cDNAs for human IMP dehydrogenase
@ast
Two distinct cDNAs for human IMP dehydrogenase
@en
Two distinct cDNAs for human IMP dehydrogenase
@nl
prefLabel
Two distinct cDNAs for human IMP dehydrogenase
@ast
Two distinct cDNAs for human IMP dehydrogenase
@en
Two distinct cDNAs for human IMP dehydrogenase
@nl
P2093
P3181
P1476
Two distinct cDNAs for human IMP dehydrogenase
@en
P2093
P304
P3181
P407
P577
1990-03-25T00:00:00Z